Not available
Quote | Veru Inc. (NASDAQ:VERU)
Last: | $1.32 |
---|---|
Change Percent: | -1.46% |
Open: | $1.39 |
Close: | $1.32 |
High: | $1.39 |
Low: | $1.25 |
Volume: | 1,568,423 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Veru Inc. (NASDAQ:VERU)
MIAMI, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced Ste...
MIAMI, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced tha...
Message Board Posts | Veru Inc. (NASDAQ:VERU)
Subject | By | Source | When |
---|---|---|---|
$VERU...............................https://stockcharts.com/h-sc/ui?s=$VERU&p=W&b= | glenn1919 | investorshub | 04/22/2023 12:20:37 PM |
Ther meme stock..good nws | Jayzp | investorshub | 04/21/2023 2:33:21 PM |
I still say in my opinion the shareholders | Alleyba1 | investorshub | 02/23/2023 3:41:42 PM |
I believe in the latest $VERU filing Blackrock | Alleyba1 | investorshub | 02/13/2023 5:42:12 PM |
$VERU.................................https://stockcharts.com/h-sc/ui?s=$VERU&p=W& | glenn1919 | investorshub | 02/10/2023 9:22:33 PM |
News, Short Squeeze, Breakout and More Instantly...
MIAMI, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced Ste...
MIAMI, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innov...
MIAMI, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced tha...